240 related articles for article (PubMed ID: 12617904)
21. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
[TBL] [Abstract][Full Text] [Related]
22. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds.
Balaydin HT; Durdaği S; Ekinci D; Sentürk M; Göksu S; Menzek A
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):467-75. PubMed ID: 21815772
[TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates.
Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2003 Dec; 46(25):5471-7. PubMed ID: 14640555
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
[TBL] [Abstract][Full Text] [Related]
28. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
[TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.
Temperini C; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Aug; 18(15):4282-6. PubMed ID: 18640037
[TBL] [Abstract][Full Text] [Related]
30. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
[TBL] [Abstract][Full Text] [Related]
33. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2003 May; 46(11):2197-204. PubMed ID: 12747791
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
35. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(3):567-71. PubMed ID: 15664814
[TBL] [Abstract][Full Text] [Related]
37. Quantitative structure activity relationship studies of sulfamide derivatives as carbonic anhydrase inhibitor: as antiglaucoma agents.
Kumar S; Singh V; Tiwari M
Med Chem; 2007 Jul; 3(4):379-86. PubMed ID: 17627576
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
Winum JY; Pastorekova S; Jakubickova L; Montero JL; Scozzafava A; Pastorek J; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(3):579-84. PubMed ID: 15664816
[TBL] [Abstract][Full Text] [Related]
39. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
[TBL] [Abstract][Full Text] [Related]
40. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.
Winum JY; Innocenti A; Vullo D; Montero JL; Supuran CT
Bioorg Med Chem Lett; 2009 Sep; 19(17):5082-5. PubMed ID: 19632111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
